Transport of Ebolavirus Nucleocapsids Is Dependent on Actin Polymerization: Live-Cell Imaging Analysis of Ebolavirus-Infected Cells

Journal of Infectious Diseases

Volumn 212, Issue , 2015, Pages S160-S166

  Schudt, Gordian ^a   Dolnik, Olga ^a   Kolesnikova, Larissa ^a   Biedenkopf, Nadine ^a   Herwig, Astrid ^a   Becker, Stephan ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

cytoskeleton inhibitors; dual color time lapse imaging; fluorescent tag; GFP; intracellular transport; nucleocapsid; recombinant ebola virus; VP30

Indexed keywords

ACTIN RELATED PROTEIN 2-3 COMPLEX; F ACTIN; GREEN FLUORESCENT PROTEIN; NEURAL WISKOTT ALDRICH SYNDROME PROTEIN; NUCLEOCAPSID PROTEIN; UNCLASSIFIED DRUG; VIRAL PROTEIN 30; ACTIN; TRANSCRIPTION FACTOR; VIRUS PROTEIN; VP30 PROTEIN, EBOLA VIRUS;

ACTIN POLYMERIZATION; ARTICLE; CELL INCLUSION; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; CYTOPLASM; DEPOLYMERIZATION; EBOLAVIRUS; FILOPODIUM; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MICROTUBULE; NONHUMAN; PRIORITY JOURNAL; TIME LAPSE IMAGING; VIRUS NUCLEOCAPSID; VIRUS RELEASE; WESTERN BLOTTING; CYTOSKELETON; METABOLISM; PHYSIOLOGY; PSEUDOPODIUM; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE;

ACTINS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CELL MEMBRANE; CYTOPLASM; CYTOSKELETON; EBOLAVIRUS; GREEN FLUORESCENT PROTEINS; HUMANS; INCLUSION BODIES; NUCLEOCAPSID; PSEUDOPODIA; TRANSCRIPTION FACTORS; VIRAL PROTEINS;

EID: 84939651402     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv083     Document Type: Article

References (37)

1. Geisbert TW, Feldmann H. Recombinant vesicular stomatitis virusbased vaccines against Ebola and Marburg virus infections. J Infect Dis 2011; 204(suppl 3):S1075-81.
2. Team WHOER. Ebola virus disease in West Africa-The first 9 months of the epidemic and forward projections. N Engl J Med 2014; 371:1481-95.
3. Hoenen T, Groseth A, Falzarano D, Feldmann H. Ebola virus: unravelling pathogenesis to combat a deadly disease. Trends Mol Med 2006; 12:206-15.
4. Hoenen T, Feldmann H. Ebolavirus in West Africa, and the use of experimental therapies or vaccines. BMC biology 2014; 12:80.
5. Marzi A, Feldmann H. Ebola virus vaccines: an overview of current approaches. Expert Rev Vaccines 2014; 13:521-31.
6. Dessen A, Forest E, Volchkov V, Dolnik O, Klenk HD,WeissenhornW. Crystallization and preliminary X-ray analysis of the matrix protein from Ebola virus. Acta Crystallogr D Biol Crystallogr 2000; 56:758-60.
7. Kuhn JH, Becker S, Ebihara H, et al. Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol 2010; 155:2083-103.
8. Sanchez A, Geisbert T, Feldmann H. Filoviridae-Marburg and Ebola viruses. In: Knipe D, ed. Fields virology. 5th ed. Vol 1. Philadelphia, PA: Lippincott Williams and Wilkins, 2007:1410-48.
9. Kuhn JH, Andersen KG, Bao Y, et al. Filovirus RefSeq entries: evaluation and selection of filovirus type variants, type sequences, and names. Viruses 2014; 6:3663-82.
10. Bharat TA, Noda T, Riches JD, et al. Structural dissection of Ebola virus and its assembly determinants using cryo-electron tomography. Proc Natl Acad Sci U S A 2012; 109:4275-80.
11. Bharat TA, Riches JD, Kolesnikova L, et al. Cryo-electron tomography of Marburg virus particles and their morphogenesis within infected cells. PLoS Biol 2011; 9:e1001196.
12. KileyMP, Regnery RL, Johnson KM. Ebola virus: identification of virion structural proteins. J Gen Virol 1980; 49:333-41.
13. Welsch S, Kolesnikova L, Krahling V, Riches JD, Becker S, Briggs JA. Electron tomography reveals the steps in filovirus budding. PLoS Pathog 2010; 6:e1000875.
14. Geisbert TW, Jahrling PB. Differentiation of filoviruses by electron microscopy. Virus Res 1995; 39:129-50.
15. WeissenhornW, Carfi A, Lee KH, Skehel JJ,Wiley DC. Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain. Molecular cell 1998; 2:605-16.
16. Timmins J, Ruigrok RW, Weissenhorn W. Structural studies on the Ebola virus matrix protein VP40 indicate that matrix proteins of enveloped RNA viruses are analogues but not homologues. FEMS Microbiol Lett 2004; 233:179-86.
17. Falzarano D, Krokhin O, Van Domselaar G, et al. Ebola sGP-The first viral glycoprotein shown to be C-mannosylated. Virology 2007; 368: 83-90.
18. Mittler E, Kolesnikova L, Herwig A, Dolnik O, Becker S. Assembly of the Marburg virus envelope. Cell Microbiol 2013; 15:270-84.
19. Sodeik B. Mechanisms of viral transport in the cytoplasm. Trends Microbiol 2000; 8:465-72.
20. Schudt G, Kolesnikova L, Dolnik O, Sodeik B, Becker S. Live-cell imaging of Marburg virus-infected cells uncovers actin-dependent transport of nucleocapsids over long distances. Proc Natl Acad Sci U S A 2013; 110:14402-7.
21. Groseth A, Marzi A, Hoenen T, et al. The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo. PLoS Pathog 2012; 8:e1002847.
22. Hoenen T, Shabman RS, Groseth A, et al. Inclusion bodies are a site of ebolavirus replication. J Virol 2012; 86:11779-88.
23. Kolesnikova L, Bohil AB, Cheney RE, Becker S. Budding of Marburgvirus is associated with filopodia. Cell Microbiol 2006; 9:939-51.
24. Kolesnikova L, Mittler E, Schudt G, Shams-Eldin H, Becker S. Phosphorylation of Marburg virus matrix protein VP40 triggers assembly of nucleocapsids with the viral envelope at the plasma membrane. Cell Microbiol 2012; 14:182-97.
25. Dolnik O, Kolesnikova L, Welsch S, Strecker T, Schudt G, Becker S. Interaction with tsg101 is necessary for the efficient transport and release of nucleocapsids in Marburg virus-infected cells. PLoS Pathog 2014; 10: e1004463.
26. Martinez MJ, Biedenkopf N, Volchkova V, et al. Role of Ebola virus VP30 in transcription reinitiation. J Virol 2008; 82:12569-73.
27. Nanbo A, Watanabe S, Halfmann P, Kawaoka Y. The spatio-temporal distribution dynamics of Ebola virus proteins and RNA in infected cells. Sci Rep 2013; 3:1206.
28. Nolen BJ, Tomasevic N, Russell A, et al. Characterization of two classes of small molecule inhibitors of Arp2/3 complex. Nature 2009; 460: 1031-4.
29. Park H, Cox D. Cdc42 regulates Fc gamma receptor-mediated phagocytosis through the activation and phosphorylation of Wiskott-Aldrich syndrome protein (WASP) and neural-WASP. Mol Biol Cell 2009; 20:4500-8.
30. Goldberg MB. Actin-based motility of intracellular microbial pathogens. Microbiol Mol Biol Rev 2001; 65:595-626.
31. Rottner K, Hanisch J, Campellone KG. WASH, WHAMM and JMY: regulation of Arp2/3 complex and beyond. Trends Cell Biol 2010; 20:650-61.
32. Havrylenko S, Noguera P, Abou-Ghali M, et al.WAVE binds Ena/VASP for enhanced Arp2/3 complex-based actin assembly. Mol Biol Cell 2015; 26:55-65.
33. Machesky LM, Insall RH. Scar1 and the related Wiskott-Aldrich syndrome protein, WASP, regulate the actin cytoskeleton through the Arp2/3 complex. Curr Biol 1998; 8:1347-56.
34. Kolesnikova L, Bohil AB, Cheney RE, Becker S. Budding of Marburgvirus is associated with filopodia. Cell Microbiol 2007; 9:939-51.
35. Lehmann MJ, Sherer NM, Marks CB, Pypaert M, MothesW. Actin-and myosin-driven movement of viruses along filopodia precedes their entry into cells. J Cell Biol 2005; 170:317-25.
36. Sherer NM, Lehmann MJ, Jimenez-Soto LF, Horensavitz C, Pypaert M, MothesW. Retroviruses can establish filopodial bridges for efficient cellto-cell transmission. Nat Cell Biol 2007; 9:310-5.
37. Kerber ML, Jacobs DT, Campagnola L, et al. A novel form of motility in filopodia revealed by imaging myosin-X at the single-molecule level. Curr Biol 2009; 19:967-73.